
May 6 (Reuters) - Bavarian Nordic A/S BAVA.CO:
AWARDED CONTRACT OPTIONS FROM THE U.S. GOVERNMENT FOR PRODUCTION AND SUPPLY OF FREEZE-DRIED SMALLPOX/MPOX VACCINES
EXERCISED OPTIONS TOTAL USD 143.6 MILLION
SECURES MANUFACTURING AND SUPPLY OF FREEZE-DRIED JYNNEOS® TO U.S. IN 2026
FINANCIAL GUIDANCE FOR 2025 REMAINS UNCHANGED
BARDA EXERCISED ADDITIONAL OPTIONS VALUED AT USD 143.6 MILLION UNDER EXISTING CONTRACT